Table 1.
Characteristics of our high-risk prostate cancer (PCa) cohort.
| n | 142 |
|---|---|
| age at surgery | 66 (47–81) |
| initial PSA (µg/L) | 35.71 (20–597) |
| follow-up (months) | 82.5 (1–154) |
| Gleason Score | |
| 6 | n = 3 |
| 7 | n = 45 |
| 8 | n = 46 |
| 9 | n = 36 |
| 10 | n = 12 |
| pT stage | |
| 2a | n = 4 |
| 2b | n = 14 |
| 2c | n = 3 |
| 3a | n = 41 |
| 3b | n = 59 |
| 4 | n = 21 |
| PSA progress | |
| yes (n) | n = 42 |
| no (n) | n = 100 |
| Clinical progress | |
| yes (n) | n = 20 |
| no (n) | n = 122 |
“Age at surgery,” “initial prostate-specific antigen (PSA),” and “follow-up” variables are characterized as median values and an absolute range. pT stage: pathologic T stage.